These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 1570838)

  • 101. Genetic Testing for
    Zhu GD; Dawson E; Huskey A; Gordon RJ; Del Tredici AL
    Pharmgenomics Pers Med; 2020; 13():405-414. PubMed ID: 33061533
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
    J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Personalized pediatric anesthesia and pain management: problem-based review.
    Packiasabapathy S; Rangasamy V; Horn N; Hendrickson M; Renschler J; Sadhasivam S
    Pharmacogenomics; 2020 Jan; 21(1):55-73. PubMed ID: 31849281
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Pharmacogenomic considerations for medications in the perioperative setting.
    Jhun EH; Apfelbaum JL; Dickerson DM; Shahul S; Knoebel R; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenomics; 2019 Jul; 20(11):813-827. PubMed ID: 31411557
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.
    Munir S; Habib R; Awan S; Bibi N; Tanveer A; Batool S; Nurulain SM
    J Mol Neurosci; 2019 Mar; 67(3):445-455. PubMed ID: 30707402
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Purification of human butyrylcholinesterase from frozen Cohn fraction IV-4 by ion exchange and Hupresin affinity chromatography.
    Schopfer LM; Lockridge O; David E; Hinrichs SH
    PLoS One; 2019; 14(1):e0209795. PubMed ID: 30625168
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Butyrylcholinesterase and Acetylcholinesterase polymorphisms in Multiple Sclerosis patients: implication in peripheral inflammation.
    Reale M; Costantini E; Di Nicola M; D'Angelo C; Franchi S; D'Aurora M; Di Bari M; Orlando V; Galizia S; Ruggieri S; Stuppia L; Gasperini C; Tata AM; Gatta V
    Sci Rep; 2018 Jan; 8(1):1319. PubMed ID: 29358722
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Association between butyrylcholinesterase K variant and mild cognitive impairment in the Thai community-dwelling patients.
    Pongthanaracht N; Yanarojana S; Pinthong D; Unchern S; Thithapandha A; Assantachai P; Supavilai P
    Clin Interv Aging; 2017; 12():897-901. PubMed ID: 28603409
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia.
    Kandiah N; Pai MC; Senanarong V; Looi I; Ampil E; Park KW; Karanam AK; Christopher S
    Clin Interv Aging; 2017; 12():697-707. PubMed ID: 28458525
    [TBL] [Abstract][Full Text] [Related]  

  • 110. High-Confidence Qualitative Identification of Organophosphorus Nerve Agent Adducts to Human Butyrylcholinesterase.
    Mathews TP; Carter MD; Johnson D; Isenberg SL; Graham LA; Thomas JD; Johnson RC
    Anal Chem; 2017 Feb; 89(3):1955-1964. PubMed ID: 28208252
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
    Lockridge O; Norgren RB; Johnson RC; Blake TA
    Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Butyrylcholinesterase K variant and Alzheimer's disease risk: a meta-analysis.
    Wang Z; Jiang Y; Wang X; Du Y; Xiao D; Deng Y; Wang J
    Med Sci Monit; 2015 May; 21():1408-13. PubMed ID: 25978873
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Butyrylcholinesterase genotype and enzyme activity in relation to Gulf War illness: preliminary evidence of gene-exposure interaction from a case-control study of 1991 Gulf War veterans.
    Steele L; Lockridge O; Gerkovich MM; Cook MR; Sastre A
    Environ Health; 2015 Jan; 14():4. PubMed ID: 25575675
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Butyrylcholinesterase genetic variants: association with cocaine dependence and related phenotypes.
    Negrão AB; Pereira AC; Guindalini C; Santos HC; Messas GP; Laranjeira R; Vallada H
    PLoS One; 2013; 8(11):e80505. PubMed ID: 24312228
    [TBL] [Abstract][Full Text] [Related]  

  • 115. A review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer's disease.
    Nordberg A; Ballard C; Bullock R; Darreh-Shori T; Somogyi M
    Prim Care Companion CNS Disord; 2013; 15(2):. PubMed ID: 23930233
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Recombinant human butyrylcholinesterase as a new-age bioscavenger drug: development of the expression system.
    Ilyushin DG; Haertley OM; Bobik TV; Shamborant OG; Surina EA; Knorre VD; Masson P; Smirnov IV; Gabibov AG; Ponomarenko NA
    Acta Naturae; 2013 Jan; 5(1):73-84. PubMed ID: 23556132
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Recovery of residual curarization after red blood cell transfusion.
    Eckle VS; Schmid E; Fehm T; Grasshoff C
    Med Sci Monit; 2012 Nov; 18(11):CS91-3. PubMed ID: 23111747
    [TBL] [Abstract][Full Text] [Related]  

  • 118. GWAS of butyrylcholinesterase activity identifies four novel loci, independent effects within BCHE and secondary associations with metabolic risk factors.
    Benyamin B; Middelberg RP; Lind PA; Valle AM; Gordon S; Nyholt DR; Medland SE; Henders AK; Heath AC; Madden PA; Visscher PM; O'Connor DT; Montgomery GW; Martin NG; Whitfield JB
    Hum Mol Genet; 2011 Nov; 20(22):4504-14. PubMed ID: 21862451
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Biochemical and genetic analysis of butyrylcholinesterase (BChE) in a family, due to prolonged neuromuscular blockade after the use of succinylcholine.
    Garcia DF; Oliveira TG; Molfetta GA; Garcia LV; Ferreira CA; Marques AA; Silva WA
    Genet Mol Biol; 2011 Jan; 34(1):40-4. PubMed ID: 21637541
    [TBL] [Abstract][Full Text] [Related]  

  • 120. BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.
    Chianella C; Gragnaniello D; Maisano Delser P; Visentini MF; Sette E; Tola MR; Barbujani G; Fuselli S
    Eur J Clin Pharmacol; 2011 Nov; 67(11):1147-57. PubMed ID: 21630031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.